These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3582508

  • 21. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways.
    Araie M, Maurice DM.
    Exp Eye Res; 1991 Jan; 52(1):27-39. PubMed ID: 1714398
    [Abstract] [Full Text] [Related]

  • 22. Technical variables in vitreous fluorophotometry.
    Conway BP.
    Graefes Arch Clin Exp Ophthalmol; 1985 Jan; 222(4-5):194-201. PubMed ID: 3979842
    [Abstract] [Full Text] [Related]

  • 23. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y, Tsukahara Y, Saito I, Kondo T.
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [Abstract] [Full Text] [Related]

  • 24. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP, Jones CW, Rusin MM.
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [Abstract] [Full Text] [Related]

  • 25. Transport of fluorescein monoglucuronide out of the vitreous.
    Kitano S, Nagataki S.
    Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):998-1001. PubMed ID: 3710739
    [Abstract] [Full Text] [Related]

  • 26. Factors affecting vitreous fluorescence.
    Mosier MA.
    Graefes Arch Clin Exp Ophthalmol; 1985 Jun; 222(4-5):202-5. PubMed ID: 3979843
    [Abstract] [Full Text] [Related]

  • 27. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP, Zeimer RC, Rusin MM, Cunha-Vaz JG.
    Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634
    [Abstract] [Full Text] [Related]

  • 28. Vitreous fluorophotometry in rats with streptozocin-induced diabetes.
    Vine AK, Kisly AM, Betz AL, Howatt WF.
    Arch Ophthalmol; 1984 Jul; 102(7):1083-5. PubMed ID: 6743087
    [Abstract] [Full Text] [Related]

  • 29. Binding of fluorescein to vitreous in vitro.
    Knudsen LL.
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):352-7. PubMed ID: 3618161
    [Abstract] [Full Text] [Related]

  • 30. Ocular fluorescein kinetics before and after vitrectomy on swine.
    Knudsen LL, Dissing T, Hansen MN, Nielsen-Kudsk F.
    Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):832-9. PubMed ID: 11789863
    [Abstract] [Full Text] [Related]

  • 31. [Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. 5. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects].
    Yoshida A, Murakami K, Kojima M.
    Nippon Ganka Gakkai Zasshi; 1986 Apr; 90(4):589-94. PubMed ID: 3751759
    [No Abstract] [Full Text] [Related]

  • 32. Calcein: a new dye for evaluation of the blood-retinal barrier by fluorophotometry.
    Golshani MR, Khoobehi B, Peyman GA.
    Int Ophthalmol; 1986 Apr; 17(6):349-53. PubMed ID: 8063478
    [Abstract] [Full Text] [Related]

  • 33. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP, Zeimer RC, Rusin M, Cunha-Vaz JG.
    Graefes Arch Clin Exp Ophthalmol; 1985 Apr; 222(4-5):266. PubMed ID: 3979854
    [Abstract] [Full Text] [Related]

  • 34. Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection.
    Khoobehi B, Stradtmann MO, Peyman GA, Aly OM.
    Ophthalmic Surg; 1991 Mar; 22(3):175-80. PubMed ID: 2030905
    [Abstract] [Full Text] [Related]

  • 35. Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects.
    Bungay PM, Roy MS, Bonner RF.
    Arch Ophthalmol; 1989 Sep; 107(9):1321-7. PubMed ID: 2783065
    [Abstract] [Full Text] [Related]

  • 36. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW, Cunha-Vaz JG, Zeimer RC, Rusin MM, Langenberg PW, Vygantas CM, Tso MO, Jonasson O.
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [Abstract] [Full Text] [Related]

  • 37. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP, Rusin MM.
    Graefes Arch Clin Exp Ophthalmol; 1986 May; 224(5):419-22. PubMed ID: 3093315
    [Abstract] [Full Text] [Related]

  • 38. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.
    Blair NP, Evans MA, Lesar TS, Willett M.
    Graefes Arch Clin Exp Ophthalmol; 1989 May; 227(2):114-7. PubMed ID: 2721978
    [Abstract] [Full Text] [Related]

  • 39. Vitreous laser absorption following fluorescein angiography in diabetic patients.
    Azzolini C, Fantaguzzi S, Brancato R, Docchio F, Bandello F, Guarisco L.
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234(8):488-92. PubMed ID: 8858353
    [Abstract] [Full Text] [Related]

  • 40. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ, Ohrt V.
    Int J Microcirc Clin Exp; 1983 Aug; 2(3):207-13. PubMed ID: 6381356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.